Clinical Trials Logo

Periprocedural Myocardial Damage clinical trials

View clinical trials related to Periprocedural Myocardial Damage.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02908776 Recruiting - Clinical trials for Chronic Stable Angina

MYocardial DAmage AND MIcrobiota STUDY

MYDA-MI
Start date: September 2016
Phase: N/A
Study type: Interventional

MYDA-MI study is a randomized, placebo controlled, double blind study performed in San Filippo Neri Hospital, Roma, Italy. The planned study duration is 18 months. The objectives are to assess the effects of pre-treatment with probiotic Ecoviesel on the incidence and magnitude of peri-procedural myocardial damage caused by coronary angioplasty in stable patients. 250 patients with chronic stable angina scheduled for a coronary angiography and possible ad hoc angioplasty will be randomized to receive pre-treatment with Ecoviesel sachets (each sachet contains 200 billions bacteria) or Placebo. The pre-treatment dosage will be 4 sachets of probiotic Ecoviesel or placebo for at least 2 weeks before the planned procedure. In patients undergoing angioplasty the same treatment will be continued for 4 weeks after PCI with secondary outcome measures performed at the end of this second stage.